nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antiaromatase Agents After Adjuvant Tamoxifen: Rationale and Clinical Implications
|
Mamounas, Eleftherios P. |
|
2000 |
1 |
S1 |
p. S22-S27 6 p. |
artikel |
2 |
Antiaromatase Agents: Preclinical Data and Neoadjuvant Therapy
|
Miller, William R. |
|
2000 |
1 |
S1 |
p. S9-S14 6 p. |
artikel |
3 |
Comparison of In Vitro Exemestane Activity Versus Other Antiaromatase Agents
|
Soudon, Jacques |
|
2000 |
1 |
S1 |
p. S68-S73 6 p. |
artikel |
4 |
Epirubicin in Breast Cancer: Present and Future
|
Levine, Mark |
|
2000 |
1 |
S1 |
p. S62-S67 6 p. |
artikel |
5 |
Exemestane Improves Survival in Metastatic Breast Cancer: Results of a Phase III Randomized Study
|
Kaufmann, Manfred |
|
2000 |
1 |
S1 |
p. S15-S18 4 p. |
artikel |
6 |
Exemestane in Breast Cancer: Current Status and Future Directions
|
Lønning, Per E. |
|
2000 |
1 |
S1 |
p. S28-S33 6 p. |
artikel |
7 |
Introduction
|
Piccart, Martine J. |
|
2000 |
1 |
S1 |
p. S7-S8 2 p. |
artikel |
8 |
Overview of Epirubicin-Based Adjuvant Therapy in Breast Cancer
|
Untch, Michael |
|
2000 |
1 |
S1 |
p. S41-S45 5 p. |
artikel |
9 |
Promising Results with Exemestane in the First-Line Treatment of Metastatic Breast Cancer: A Randomized Phase II EORTC Trial with a Tamoxifen Control
|
Paridaens, Robert |
|
2000 |
1 |
S1 |
p. S19-S21 3 p. |
artikel |
10 |
Rationale and Design of a Phase III Trial of Adjuvant Sequential Epirubicin/Cyclophosphamide and Taxane Versus Concurrent Epirubicin/Taxane in Operable Node-Positive Breast Cancer
|
Perez, Edith A. |
|
2000 |
1 |
S1 |
p. S52-S56 5 p. |
artikel |
11 |
Rationale and Use of Epirubicin-Based Therapy in the Adjuvant Setting
|
Mouridsen, Henning T. |
|
2000 |
1 |
S1 |
p. S34-S40 7 p. |
artikel |
12 |
Role of Epirubicin in Advanced Breast Cancer
|
Conte, Pier Franco |
|
2000 |
1 |
S1 |
p. S46-S51 6 p. |
artikel |
13 |
Selection Criteria for Epirubicin-Based Adjuvant Chemotherapy in Node-Negative Breast Cancer
|
Jänicke, Fritz |
|
2000 |
1 |
S1 |
p. S57-S61 5 p. |
artikel |
14 |
The Role of Vascular Endothelial Growth Factor (VEGF) in Tumor Angiogenesis and Early Clinical Development of VEGFReceptor Kinase Inhibitors
|
Verheul, Henk M.W. |
|
2000 |
1 |
S1 |
p. S80-S84 5 p. |
artikel |
15 |
Treating Breast Precancer
|
O'Shaughnessy, Joyce A. |
|
2000 |
1 |
S1 |
p. S74-S79 6 p. |
artikel |